Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

S&P Biotech SPDR (XBI)

S&P Biotech SPDR (XBI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family State Street Global Advisors
  • Assets Under Management 5,568,029,200
  • Market Capitalization, $K 5,568,029
  • Shares Outstanding, K 47,525
  • 60-Month Beta 1.52
Trade XBI with:
  • Price/Earnings ttm 12.93
  • Annual Dividend & Yield 0.11 (0.09%)
  • Most Recent Dividend 0.089 on 09/21/20
  • Management Fee 0.35%
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
105.89 +11.09%
on 09/24/20
122.82 -4.23%
on 10/13/20
+8.48 (+7.77%)
since 09/23/20
3-Month
100.64 +16.88%
on 09/04/20
122.82 -4.23%
on 10/13/20
+2.71 (+2.36%)
since 07/23/20
52-Week
62.94 +86.89%
on 03/18/20
122.82 -4.23%
on 10/13/20
+37.20 (+46.25%)
since 10/23/19

Most Recent Stories

More News
Moderna Expects COVID-19 Vaccine Data in November: ETFs to Gain

Positive comment on coronavirus vaccine progress from Moderna's (MRNA) CEO during The Wall Street Journal's annual Tech Live conference has gained investors attention and raised vaccine optimism.

IBB : 136.49 (+0.25%)
XBI : 117.63 (+0.50%)
BBH : 158.91 (-0.08%)
BTEC : 50.23 (+0.45%)
IDNA : 39.66 (+0.03%)
GERM : 28.65 (+0.56%)
Trump vs. Biden: ETF Strategies for the Election Outcome

How the presidential election could impact your portfolio

XHB : 55.82 (+1.51%)
TAN : 71.12 (+0.06%)
XHE : 103.38 (+0.47%)
CNRG : 78.87 (-0.48%)
AMZN : 3,204.40 (+0.88%)
AAPL : 115.04 (-0.61%)
FB : 284.79 (+2.40%)
XBI : 117.63 (+0.50%)
Weekly ETF Roundup: Broad U.S. Equity Tops, Biotech Flops

ETFs overall gathered about $18.5 billion capital last week, bringing year-to-date inflows of $352.6 billion, ahead of the $211.7 billion seen at this same time a year ago.

JNJ : 145.24 (+0.11%)
PFE : 38.18 (+2.00%)
LLY : 142.38 (+0.52%)
JNK : 105.51 (+0.10%)
QQQ : 284.74 (+0.20%)
HYG : 84.87 (+0.12%)
EFA : 64.98 (+0.65%)
IWM : 163.07 (+0.58%)
XBI : 117.63 (+0.50%)
VTI : 176.84 (+0.33%)
KRE : 42.59 (+1.14%)
VXUS : 53.67 (+0.56%)
FTCS : 64.47 (+0.51%)
ONLN : 67.39 (+0.78%)
Trump vs. Biden: ETF Strategies for the Election Outcome

How the presidential election could impact your portfolio.

AMZN : 3,204.40 (+0.88%)
AAPL : 115.04 (-0.61%)
FB : 284.79 (+2.40%)
TAN : 71.12 (+0.06%)
XBI : 117.63 (+0.50%)
XHE : 103.38 (+0.47%)
CNRG : 78.87 (-0.48%)
Biotech ETFs to Shine on Coronavirus Antibodies Progress

With Regeneron Pharmaceuticals and Eli Lilly & Company requesting the FDA for an Emergency Use Authorization for their antibody therapy treatments, the biotech space is filled with optimism.

IBB : 136.49 (+0.25%)
XBI : 117.63 (+0.50%)
BBH : 158.91 (-0.08%)
PBE : 59.67 (+0.12%)
ARKG : 70.11 (+1.18%)
Biotech ETFs to Gain on Trump's COVID-19 Treatment Protocol

The progress in Trump's health condition and his treatment protocols are continuously under the purview of market participants and are impacting Wall Street movements.

IBB : 136.49 (+0.25%)
XBI : 117.63 (+0.50%)
BBH : 158.91 (-0.08%)
PBE : 59.67 (+0.12%)
ARKG : 70.11 (+1.18%)
Healthcare ETFs Pop on Bristol Myers-MyoKardia Deal

These funds could be the best ways for investors to tap the opportunity arising from the Bristol Myers-MyoKardia deal and will likely see smooth trading in the months to come.

BMY : 60.13 (-1.04%)
XBI : 117.63 (+0.50%)
XPH : 46.39 (+0.63%)
BBC : 41.07 (+0.20%)
SBIO : 44.56 (+0.86%)
MYOK : 222.97 (+0.37%)
ARKG : 70.11 (+1.18%)
Top-Performing Biotech ETFs Amid the Coronavirus Crisis

The race to introduce vaccine and treatment of coronavirus is opening up opportunities, making the biotech sector a prospective space for investments.

IBB : 136.49 (+0.25%)
XBI : 117.63 (+0.50%)
BBH : 158.91 (-0.08%)
ARKG : 70.11 (+1.18%)
Biotech ETFs in Focus as the COVID-19 Vaccine Race Intensifies

Johnson & Johnson's entry into the late-stage trials has increased optimism in the coronavirus vaccine development.

IBB : 136.49 (+0.25%)
XBI : 117.63 (+0.50%)
BBH : 158.91 (-0.08%)
FBT : 157.62 (+0.10%)
ARKG : 70.11 (+1.18%)
Should You Invest in the Invesco Dynamic Biotechnology Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 59.67 (+0.12%)
REGN : 579.81 (+0.71%)
AMGN : 227.16 (-0.36%)
IBB : 136.49 (+0.25%)
OPK : 4.30 (+0.70%)
XBI : 117.63 (+0.50%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The SPDR SP Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Biotechnology Select Industry Index.

See More

Key Turning Points

2nd Resistance Point 118.92
1st Resistance Point 118.27
Last Price 117.63
1st Support Level 116.54
2nd Support Level 115.46

See More

52-Week High 122.82
Last Price 117.63
Fibonacci 61.8% 99.95
Fibonacci 50% 92.88
Fibonacci 38.2% 85.81
52-Week Low 62.94

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar